Pfizer agrees to buy Seagen for USD 43 bn
Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering class of targeted cancer drugs, The Wall Street Journal reported.
Source: parisguardian.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Executives Said. Real-time updates on events, politics, business and more.